Max Rudicel
Emergency Medicine · Muncie, INNPI 1770582785
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 14.1% — the pattern of someone who eats at a lot of different presentations. Among emergency medicine clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 36 payments — averaging $17.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$91
- Axsome Therapeutics, Inc.$54
- AstraZeneca$50
- AbbVie$48
- Exact Sciences$48
- Corium, LLC$46
- plus $308 from 16 others
What the payments were for
- Food & beverage$645100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 2 | $91 |
| Axsome Therapeutics, Inc. | 3 | $54 |
| AstraZeneca | 3 | $50 |
| AbbVie | 3 | $48 |
| Exact Sciences | 3 | $48 |
| Corium, LLC | 3 | $46 |
| GSK | 3 | $40 |
| Lilly USA, LLC | 2 | $34 |
| Sobi, Inc | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Novo Nordisk | 1 | $20 |
| Neurocrine Biosciences, Inc. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $17 |
| Johnson & Johnson | 1 | $17 |
| Boehringer Ingelheim | 1 | $16 |
| Indivior Inc. | 1 | $16 |
| Novartis | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
| Biogen | 1 | $14 |
| Lundbeck LLC | 1 | $14 |
| Bayer | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
How this compares
$645 in reported general payments places this provider in the 90th percentile of 1,073 emergency medicine providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 16 | $2,704 |
| Boostrix TdapDiphth,pertuss(Acell),tet Vac | 21 | $1,456 |
| Gabapentin | 65 | $733 |
| Clonazepam | 86 | $644 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 16 | $325 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $281 |
| Carisoprodol | 40 | $179 |
| Atorvastatin Calcium | 14 | $137 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $122 |
| Nitroglycerin | 12 | $81 |
| Temazepam | 23 | $68 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in Muncie
- Jan KornilowMuncie$1K
- Roy AbrahamPortland$80K
- Michael MartinoBedford$67K
- Andrew OfferleFort Wayne$40K
- Dustin HollandIndianapolis$39K
- Peter PangIndianapolis$23K
- Robinson FerreIndianapolis$16K
- Daren BeamIndianapolis$13K
- Jeffrey KlineIndianapolis$12K
- Kristen ErnstingIndianapolis$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.